RNS Number : 3026S

CT Global Managed Portfolio Trust

23 July 2025

TO:                  RNS

FROM:            CT Global Managed Portfolio Trust PLC

DATE:             23 July 2025

SUBJECT:      Transaction in own shares and Issue of Equity

LEI:                  213800ZA6TW45NM9YY31

The Board of CT Global Managed Portfolio Trust PLC ("the Company") announces that on 23 July 2025 the Company purchased 75,000 Growth shares of £0.046131176 each at a price of 272.0p per Growth share to be held in treasury. The Company also allotted 475,000 Income shares of £0.046131176 each, from the Company's general business purposes blocklisting facility at a price of 120.0p per Income share. These Income shares will rank pari passu with the existing Income shares in issue and dealings are expected to commence on 25 July 2025.

Following this issue, the Company has the ability to issue 2,289,510 Income shares and 1,304,550 Growth shares under its blocklisting facilities.

Following this transaction the Company's issued share capital consists of 54,365,518 Income shares and 38,741,161 Growth shares, of which nil Income shares and 5,090,000 Growth shares are held in treasury. Therefore the total number of shares with voting rights in CT Global Managed Portfolio Trust PLC is 54,365,518 Income shares and 33,651,161 Growth shares.

The above figures (54,365,518 Income shares and 33,651,161 Growth shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CT Global Managed Portfolio Trust PLC under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:                     

Adam Norris, Columbia Threadneedle Investment Business Limited   0131 573 8360

Paul Green, Columbia Threadneedle Investment Business Limited     0131 573 8360

Ian Ridge, Columbia Threadneedle Investment Business Limited       0131 573 8316

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSQXLFLEDLBBBE